Is RADIENT TECHNOLOGIES otc stock way too aggressive for baby boomers?

In this article, we will digest RADIENT TECHNOLOGIES. Why are we still optimistic in an anticipation of a recovery. Assuming the 30 trading days horizon, RADIENT TECHNOLOGIES is expected to generate 7.55 times more return on investment than the market. However, the company is 7.55 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The market is currently generating roughly 0.09 per unit of risk. We estimate RADIENT TECHNOLOGIES as currently overvalued. The real value is approaching 0.10 per share.
Published over a year ago
View all stories for Radient Technologies | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Gabriel Shpitalnik

This firm classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The company has accumulated 5.06 M in total debt with debt to equity ratio (D/E) of 0.29, which may suggest the firm is not taking enough advantage from borrowing. RADIENT TECHNOLOGIES INC has a current ratio of 0.9, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. We provide buy or sell recommendations to complement the recent expert consensus on RADIENT TECHNOLOGIES INC. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available right now.
Investing in Radient Technologies, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Radient Technologies along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Radient Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Radient Technologies. Your research has to be compared to or analyzed against Radient Technologies' peers to derive any actionable benefits. When done correctly, Radient Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Radient Technologies.

Watch out for price decline

Please consider monitoring Radient Technologies on a daily basis if you are holding a position in it. Radient Technologies is trading at a penny-stock level, and the possibility of delisting is much higher compared to other pink sheets. However, just because the pink sheet is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Radient Technologies stock to be traded above the $1 level to remain listed. If Radient Technologies pink sheet price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is Radient Technologies's Liquidity

Radient Technologies financial leverage refers to using borrowed capital as a funding source to finance Radient Technologies ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Radient Technologies financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Radient Technologies' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Radient Technologies' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Radient Technologies's total debt and its cash.

Radient Technologies Correlation with Peers

Investors in Radient can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Radient Technologies. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Radient Technologies and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Radient is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of Radient for more details

Detailed Perspective On Radient Technologies

RADIENT TECHNOLOGIES makes 32.38 m cash and equivalents. The entity reported revenue of 353.51 K. Net Loss for the year was (10.28 M) with loss before overhead, payroll, taxes, and interest of (3.28 M). RADIENT TECHNOLOGIES is selling at 0.11. That is 1.29% increase. Today the highest price was 0.12.

Some RADIENT technical indicators suggest bounce-back

Latest Information Ratio is up to 0.04. Price may dip again. RADIENT TECHNOLOGIES INC is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about RADIENT TECHNOLOGIES implied risk. RADIENT TECHNOLOGIES INC is a potential penny stock. Although RADIENT TECHNOLOGIES may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in RADIENT TECHNOLOGIES INC. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Our Takeaway on RADIENT TECHNOLOGIES Investment

Although some companies under drug manufacturers—specialty & generic industry are still a bit expensive, RADIENT TECHNOLOGIES may offer a potential longer-term growth to shareholders. To summarize, as of 8th of July 2020, our research shows that RADIENT TECHNOLOGIES is a rather out of control investment opportunity with below average chance of bankruptcy in the next two years. From a slightly different view, the entity currently appears to be overvalued. Our up-to-date 30 days buy vs. sell advice on the firm is Strong Sell. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to exit some or all of your RADIENT TECHNOLOGIES holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to RADIENT TECHNOLOGIES.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Radient Technologies. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com